Effect of progesterone on HLA-E gene expression in JEG-3 choriocarcinoma cell line. 2009

Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo, Japan.

OBJECTIVE Among class Ib human leukocyte antigen (HLA) molecules, HLA-E is known to be a major ligand of CD94/NKG2 receptor on natural killer (NK) cells, and to play a pivotal role in recognition of extravillous trophoblasts (EVTs) by maternal immune cells. However, it is scarcely known how HLA-E expression is regulated in EVTs. METHODS In this study, we investigated whether progesterone, an essential hormone in maintaining pregnancy, regulated HLA-E expression in EVT-like cell line, JEG-3. HLA-E mRNA amount in cultured JEG-3 cells was assessed by real-time PCR and cell-surface HLA-E protein was analyzed by flowcytometry. RESULTS Real-time PCR showed 3.5-fold increase 1 hour after the addition of 1000 ng/ml progesterone. This response was diminished by the addition of RU486, an antagonist for progesterone receptor. Flowcytometry indicated that 1000 ng/ml progesterone slightly enhanced HLA-E expression on the surface of JEG-3. CONCLUSIONS These results suggest that progesterone up-regulates HLA-E expression in JEG-3 cells through the pathway mediated by progesterone receptor. Our findings might give a new insight into immunomodulatory function of progesterone at fetomaternal interface.

UI MeSH Term Description Entries
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D002822 Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). Choriocarcinomas
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097625 HLA-E Antigens Class I human histocompatibility (HLA) antigens encoded by genes at the E locus on chromosome 6. They bind a restricted subset of peptides derived from the leader peptides of other class I molecules. They primarily are involved with down-regulating cytolytic activity of NK CELLS and restricting non-canonical CD8-POSITIVE T LYMPHOCYTES. HLA E Antigens,HLA E*0101 antigen,HLA-E 0103 antigen,HLA-E*0101 antigen,HLA-E*0103,HLA-E*01:01 antigen,HLA-E*01:03 antigen
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014327 Trophoblasts Cells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface (PLACENTA). Cytotrophoblasts,Syncytiotrophoblasts,Trophoblast,Cytotrophoblast,Syncytiotrophoblast
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I

Related Publications

Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
January 2006, Human reproduction (Oxford, England),
Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
January 1991, International journal of cancer. Supplement = Journal international du cancer. Supplement,
Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
January 2017, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
June 2020, Cellular immunology,
Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
September 2009, The Journal of steroid biochemistry and molecular biology,
Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
March 2007, The Journal of steroid biochemistry and molecular biology,
Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
May 2015, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
February 2018, Cellular immunology,
Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
December 2014, Anticancer research,
Zhongying Huang, and Hironobu Hyodo, and Tomoyuki Fujii, and Takeshi Nagamatsu, and Junko Matsumoto, and Kei Kawana, and Takahiro Yamashita, and Toshiharu Yasugi, and Shiro Kozuma, and Yuji Taketani
April 2009, American journal of reproductive immunology (New York, N.Y. : 1989),
Copied contents to your clipboard!